Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations (Details)

v3.19.2
Discontinued Operations (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 31, 2019
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Net income (loss) from discontinuing operations   $ (4,462) $ 4,808 $ (6,479) $ 1,353  
REG Life Sciences | Assets held for sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Impairment loss           $ (11,226)
Other revenues   0 1,250 1,786 2,500  
Other costs of goods sold   0 (1,143) (2,200) (2,281)  
Research and development expense   (3,205) (2,458) (4,803) (8,022)  
Other income (expense), net   (7) 7,159 (12) 9,157  
Loss on sale of assets   (1,250) 0 (1,250) 0  
Pre-tax income (loss) from discontinued operations   (4,462) 4,808 (6,479) 1,354  
Income tax expense   0 0 0 0  
Net income (loss) from discontinuing operations   (4,462) $ 4,808 (6,479) $ 1,354  
Machinery and equipment, net   0   0   824
In-process research and development   0   0   13,652
Impairment recognized on assets classified as held for sale   0   0   (11,226)
Total assets classified as held for sale   $ 0   $ 0   $ 3,250
REG Life Sciences | Assets sold            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Loss on sale of assets $ 1,250